Next Article in Journal
Vulgar Psoriasis Triggered by Active Pulmonary Tuberculosis: A Case Report and Literature Review Highlighting Immunological Interactions and Genetic Susceptibility
Previous Article in Journal
Changes in Perceived Tinnitus Sound Qualities Following Internet-Based Cognitive Behavioral Therapy for Tinnitus
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series

Department of Infectology and Geographical Medicine, Faculty of Medicine, Comenius University in Bratislava, 83101 Bratislava, Slovakia
*
Author to whom correspondence should be addressed.
Clin. Pract. 2025, 15(4), 70; https://doi.org/10.3390/clinpract15040070
Submission received: 21 January 2025 / Revised: 12 March 2025 / Accepted: 21 March 2025 / Published: 28 March 2025

Abstract

:
Background: Streptococcal toxic shock syndrome (STSS) is a serious and potentially fatal complication of invasive Streptococcus pyogenes (Group A Streptococcus, GAS) infection, often stemming from severe soft tissue infections. While uncommon, tonsillitis can also lead to STSS, with lethality rates reported as high as 70%. Methods: We present three cases of patients diagnosed with tonsillitis who developed STSS. Point-of-care testing for GAS antigens was utilized to facilitate rapid diagnosis. Results: In all three cases, the characteristic clinical presentations, including scarlatiniform rash, strawberry tongue, and signs of shock with multi-organ dysfunction, were observed. Microbiological evidence confirmed ongoing GAS infections, and point-of-care testing for GAS antigens assisted in the diagnosis of tonsillitis in conjunction with STSS, enabling timely treatment interventions. Conclusions: Rapid diagnosis is crucial for the optimal management of STSS. The point-of-care testing for GAS may be useful for diagnosing STSS associated with tonsillitis.

1. Introduction

Streptococcal toxic shock syndrome (STSS) is a severe, rapidly progressive, and almost universally fatal condition if not treated promptly and correctly. The causative agent is Streptococcus pyogenes or Group A Streptococcus (GAS), according to the Lansfled classification, which produces streptococcal pyrogenic exotoxin with superantigen activity [1,2,3]. The development of clinical manifestations and complications of STSS is mediated by the interaction of streptococcal superantigens with the host immune system [4,5,6,7]. The disease is relatively rare, with a peak incidence in the elderly population. Other risk factors for the development of STSS include the presence of severe comorbidities (diabetes mellitus, immunodeficiency, and oncologic diseases), alcoholism, and impaired skin integrity [8]. The initial presentation is non-specific and often flu-like, with later development of maculopapular rash and shock with multi-organ dysfunction [9,10,11]. According to epidemiological studies, the lethality of STSS ranges from 30 to 70% [8]. It usually complicates soft tissue GAS infections. In rare cases, STSS has developed as a complication of tonsillitis or tonsillopharyngitis [12,13]. The cornerstone of appropriate management is the early administration of antibiotics, accompanied by supportive treatment of shock and surgical debridement if necessary. Early diagnosis is essential for appropriate management. This emphasises the importance of awareness of STSS, its signs and symptoms, and possible means of microbiological diagnosis. We present three cases of young patients with STSS, which developed as a complication of Streptococcus pyogenes tonsillitis, and demonstrate the usefulness of a point-of-care antigen test for Streptococcus pyogenes in the rapid diagnosis of STSS.

2. Results

2.1. Case 1

A 33-year-old obese (body mass index: 32.4 kg/m2) Caucasian female (ethnicity—Slovak, West Slavic) with a history of heroin abuse (buprenorphine/naloxone substitution therapy) presented to the Emergency Department of the Clinic of Infectious Diseases and Geographical Medicine, University Hospital in Bratislava, with a 3-day history of fever up to 41 °C, progressive weakness, malaise, pruritic rash and severe sore throat, and an approximately 6 h history of nausea, vomiting, and dyspnoea. The patient took azithromycin 500 mg orally 16 h before presentation, which was prescribed by a general practitioner. On presentation, the patient was agitated, hypotensive (60/30 mm of mercury), tachycardic (160 bpm), and tachypnoeic (36 breaths per minute). The patient tolerated only horizontal positions and any attempt to sit resulted in collapse. Physical examination revealed a generalised pink to light red confluent maculopapular rash with a sandpaper texture (Figure 1 and Figure 2), red swollen tonsils, dark red strawberry tongue, and crackles throughout the lungs. Laboratory investigations revealed elevated C-reactive protein (321 mg/L), interleukin-6 (996 pg/mL), procalcitonin (29.4 ng/mL), lactate (3.9 mmol/L), creatinine (280 umol/L), neutrophilia (24,700 cells/mL), plasma glucose (18.2 mmol/L), hyponatremia (123 mmol/L), and hypoxaemia (59 mm of mercury O2 in arterial blood). The results of laboratory tests, vital signs, and signs and symptoms at the time of presentation are shown in Table 1. Chest X-ray showed interstitial pulmonary oedema, and abdominal ultrasound showed hepatosplenomegaly. The oropharyngeal swab was antigen-positive for GAS using a rapid point-of-care test. Based on the clinical presentation and the positive GAS antigen, STSS was suspected. The patient was admitted to the intensive care unit. Empiric antimicrobial therapy (ceftriaxone 2 g every 12 h plus clindamycin 600 mg every 8 h), fluid resuscitation (30 mL of a balanced crystalloid solution per kilogram of body weight within the first 3 h), and vasopressor treatment with norepinephrine were started. Ceftriaxone was used instead of penicillin because of a history of penicillin allergy (rash). Due to hypoxaemia, the patient received oxygen via a face mask (FiO2 60%). Hyperglycaemia was treated with continuous intravenous insulin. After 12 h of treatment, vital functions stabilised, and hypotension and tachycardia resolved. The patient was oliguric during the first 12 h (urine output 175 mL/12 h); however, diuresis was restored, and renal replacement therapy was not utilised. Oropharyngeal swabs were later cultured for Streptococcus pyogenes. Blood cultures taken at the time of presentation to the emergency department were negative. This may have been due to previous antibiotic therapy. Since Streptococcus pyogenes was isolated from a non-sterile site (the tonsils) rather than from a sterile site (with blood cultures returning negative), this case can only be classified as probable STSS. The cultivation of GAS from a sterile site is required to conclude a definitive diagnosis of STSS. On the second day of treatment, the patient’s vital signs were stable, procalcitonin, creatinine, neutrophilia, and lactate decreased, and urine output was restored. However, their sore throat became more prominent and their cervical lymph nodes were swollen and tender. Ultrasound of the neck showed enlarged vascularised lymph nodes along the mm. sternocleiodmastoidei. On the third day of treatment, norepinephrine therapy was stopped. The exanthema became paler and less visible. On day 8, respiratory insufficiency resolved, supplemental oxygen therapy was discontinued, and the patient was transferred from the ICU to the general ward. The patient however evolved palmar desquamation. Parenteral antibiotics were changed to oral antibiotics. Despite clinical stabilisation, hyperglycaemia did not resolve. Glycated haemoglobin was significantly elevated (11.2%), C-peptide was normal, and antibodies to glutamic acid decarboxylase were negative. Based on these findings, the patient was diagnosed with type 2 diabetes and treated with intensive insulin therapy. The patient was discharged on day 17.

2.2. Case 2

A 20-year-old healthy Caucasian female (ethnicity—Slovak, West Slavic) presented to the Emergency Department of the Clinic of Infectious Diseases and Geographical Medicine, University Hospital in Bratislava, with a four-day history of fever up to 39 °C, severe sore throat, weakness, malaise, pruritic rash, nausea, vomiting, and diarrhoea. The patient was hypotensive (88/50 mm of mercury), tachycardic (137 beats per minute), and tachypnoeic (24 breaths per minute). Oxygen saturation measured by pulse oximetry was 92%. Physical examination revealed a generalised pink to light red maculopapular rash with a sandpaper texture. It was most prominent over the cubital region (Figure 3 and Figure 4). In the abdominal region, the exanthema was papular and pale (Figure 5). The tonsils were swollen and erythematous with purulent exudate. Objective examination revealed submandibular lymphadenopathy. Auscultation of the lungs revealed a slight crackling sound over the middle and lower parts of the lungs. The rest of the examination was unremarkable. Laboratory tests revealed elevated C-reactive protein (268 mg/L), interleukin-6 (1036 pg/mL), procalcitonin (182.7 ng/mL), lactate (2.2 mmol/L), alanine aminotransferase (112.05 UI/L), and aspartate aminotransferase (220.05 UI/L). Otherwise, the laboratory examination was unremarkable. The results of laboratory tests, vital signs, and signs and symptoms at the time of presentation are shown in Table 1. Chest X-ray showed interstitial pulmonary oedema. Abdominal ultrasound was unremarkable. The participant was not treated with antibiotics prior to presentation. The oropharyngeal swab was positive for the GAS antigen using a rapid point-of-care test. The patient was admitted to the ICU and given empiric antimicrobial therapy (penicillin 5 million units every 6 h). Based on the clinical presentation and the positive GAS antigen, STSS was suspected and clindamycin was added to the therapy at a dose of 600 mg every 8 h. The patient also underwent fluid resuscitation with 30 mL of a balanced crystalloid solution per kilogram of body weight within fast 3 h. The patient received conventional oxygen therapy due to dyspnoea and hypoxaemia. The patient responded well to fluid resuscitation (resolution of hypotension and tachycardia), and vasopressor therapy was not required. The patient was oliguric for the first 6 h, passing only 30 mL of urine. After the first 6 h and fluid replacement therapy, oliguria also resolved. On the second day of treatment, the patient’s vital signs were stable, and procalcitonin, neutrophilia, and lactate decreased. On the third day of treatment, the exanthema became lighter in colour, but desquamation of the palmar and plantar skin developed. The patient also developed strawberry tongue signs (Figure 6) and later developed palmar desquamation. Vital signs were stable and the patient was transferred to the general ward. Oropharyngeal swabs were later cultured for Streptococcus pyogenes, and blood cultures (two out of two) also revealed a pure culture of Streptococcus pyogenes. The patient met the diagnostic criteria for a definitive case of STSS. The clinical condition gradually improved, antibiotic therapy was discontinued on day 10, and the patient was discharged.

2.3. Case 3

A 38-year-old previously healthy Caucasian woman (ethnicity—Slovak, West Slavic) presented to the Emergency Department of the Clinic of Infectious Diseases and Geographical Medicine, University Hospital in Bratislava, with a four-day history of fever up to 40 degrees Celsius, progressive weakness, orthostatic collapses, pruritic rash, sore throat, nausea, and diarrhoea. On presentation, she was hypotensive (85/52 mm of mercury), tachycardic (110 beats per minute), and tachypnoeic (25 breaths per minute). The physical examination revealed a generalised bright red maculopapular rash with a sandpaper texture (Figure 7), deep red and swollen tonsils with purulent exudate, and submandibular lymphadenopathy. The physical examination was otherwise unremarkable. Laboratory investigations revealed elevated C-reactive protein (127 mg/L), interleukin-6 (438 pg/mL), procalcitonin (3.3 ng/mL), lactate (2.1 mmol/L), urea (8 mmol/L), and creatinine (128 umol/L). It also revealed mild hyponatremia (133 mmol/L) and hypoalbuminemia (27.2 g/L). The blood count revealed severe neutrophilia (22,310 cells/mL). The results of laboratory tests, vital signs, and signs and symptoms at the time of presentation are shown in Table 1. Chest X-ray revealed mild interstitial oedema. Abdominal ultrasound was unremarkable. The patient was admitted to the intensive care unit. Empiric antimicrobial therapy (ceftriaxone 2 g every 24 h) and fluid resuscitation (30 mL of a balanced crystalloid solution per kilogram of body weight within the first 3 h) were started. The oropharyngeal swab revealed antigen positivity of GAS by means of a rapid point-of-care test. Based on clinical presentation and the positive GAS antigen, STSS was suspected, and clindamycin, at a dose of 600 mg every 8 h, was added to therapy. Despite fluid resuscitation, the patient remained oliguric for the first 24 h, passing only 70 mL of urine. The next day, the patient developed dyspnoea and mild hypoxemia (oxygen saturation in the arterial blood at 92%); auscultation revealed crepitations over the lungs and chest X-ray revealed incipient interstitial oedema. Therefore, conventional oxygen therapy via nasal cannula was started. After 24 h of treatment, the vital functions stabilised, and oliguria, hypotension, and tachycardia resolved. Oropharyngeal swabs later revealed the culture of Streptococcus pyogenes. One of the three blood cultures taken at the time of presentation revealed a pure culture of Streptococcus pyogenes. On day 5, hypoxemia resolved, and the patient was transferred to the general ward. The rash became pale and only slightly apparent, and their sore throat, diarrhoea, and general weakness also resolved. Palmar desquamation evolved at day 7. Antibiotic therapy was discontinued on day 14, and the patient was discharged.

3. Discussion

We present the case series of three patients with STSS with characteristic clinical presentation and positive point-of-care antigen tests for Streptococcus pyogenes. STSS is a rare disease. The aetiological agent responsible for this syndrome is almost exclusively Streptococcus pyogenes or GAS. STSS can rarely be caused by other group B, C, and G streptococci, such as S. dysgalactiae subsp. equisimilis or S. agalactiae [10,11]. It usually complicates invasive GAS soft tissue infections such as wound infections, cellulitis, or necrotizing fasciitis. In about half of cases, the skin lesion suggestive of a GAS infection entry site is obvious [1,2,8,9,10,11]. However, in more than 40% of cases, there is no obvious primary site of infection and the presence of GAS is only detected in the baseline blood culture [12,13]. Tonsillitis is a rare cause of STSS [2]. In our cases, sore throat and enlarged tonsils with purulent discharge were among the initial presentations, and GAS was isolated from the pharynx; there were no symptoms and signs of soft tissue infection. Thus, in these cases, STSS developed as a complication of tonsillitis. STSS is a serious and often fatal clinical condition. The pathophysiology of the disease is complex and not fully understood. However, it is known to be mediated by streptococcal toxins with superantigenic activity and interaction with the host immune system. Streptococcal exotoxins are also responsible for symptoms that overlap with scarlet fever, such as strawberry tongue and maculopapular rash with a sandpaper texture [4,5].
Superantigens activate T lymphocytes non-specifically by binding to major histocompatibility complex class II and T cell receptors [6]. The excessive non-specific activation of T cells leads to the abrupt release of pro-inflammatory cytokines, causing vasodilation and capillary leakage. The subsequent decline in perfusion leads to multi-organ dysfunction and failure. Eleven streptococcal toxins can act as superantigens. They are also known as streptococcal pyrogenic exotoxins [4,5]. Genes encoding these toxins are present in the genomes of all GAS strains. Even in potentially toxigenic strains, these genes are only expressed in the presence of specific environmental factors. Therefore, the complex interaction of GAS with its human host is required to trigger the development of STSS [7].
According to CDC diagnostic criteria, the diagnosis of STSS is based on the isolation of GAS and arterial hypotension, defined by a systolic blood pressure of 90 mmHg or less in adults and evidence of multi-organ involvement. It is characterised by two or more of the following: renal dysfunction, coagulopathy, liver involvement, acute respiratory distress syndrome, a generalised erythematous macular rash that may desquamate, soft tissue necrosis including necrotizing fasciitis or myositis, or gangrene. For the confirmed case, the condition of isolation of GAS from the typically sterile site, such as blood or cerebrospinal fluid, must be met. The case is probable if GAS is isolated from a non-sterile site [8]. The diagnosis in patient 1 can be concluded as probable STSS, as the GAS was not cultured from a sterile site. The patient fulfilled the diagnostic criteria for multi-organ involvement (acute respiratory distress syndrome, hypotension, renal impairment). However, based on the clinical presentation and the absence of other causes for the patient’s condition, we can conclude with a high degree of certainty that STSS was the cause of the patient’s illness. Patient 2 had a positive blood culture for GAS and met the diagnostic criteria for multi-organ involvement (acute respiratory distress syndrome, hypotension, acute renal impairment, acute liver impairment). Patient 3 had a positive blood culture for GAS and met the diagnostic criteria for multi-organ involvement (acute respiratory distress syndrome, hypotension, tachycardia, acute renal failure). Patients 2 and 3 also presented with typical clinical signs, namely a red maculopapular rash with a sandpaper texture, strawberry tongue, and palmar desquamation.
Initial symptoms are usually non-specific. They typically include flu-like symptoms (fever, chills, myalgia, headache) and non-specific gastrointestinal symptoms (nausea, vomiting). These symptoms precede the development of hypotension and signs and symptoms of multi-organ failure by 24 to 48 h [8]. In cases when STSS originates from soft tissue infection, severe limb pain may also be the initial symptom. In rare cases of STSS associated with tonsillitis, sore throat and enlarged tonsils with purulent discharge are usually present. [10]. The main risk factors for the development of STSS are age over 65 years, impaired skin integrity, and the presence of severe comorbidities such as alcohol abuse, diabetes mellitus, oncological disease, chronic obstructive pulmonary disease, and obesity. However, young and previously healthy individuals may also be affected [9,10,11]. In our cases, the patients were under 40 years of age. One had a history of heroin abuse, was obese, and was diagnosed with type 2 diabetes during hospitalisation. The other two patients were previously healthy. The lethality of STSS is very high, ranging from 30 to 70% [8]. Without prompt administration of effective antibiotics and supportive care, STSS rapidly progresses to multi-organ failure and is often fatal. Therefore, rapid administration of appropriate therapy is essential for successful management of the disease. Given the rarity of STSS and its potentially life-threatening consequences, it is essential for emergency physicians to be proficient in recognizing its symptoms. Due to the non-specific nature of the initial symptoms and the possibility that more definitive signs, such as the rash, may not be prominently visible upon presentation, a heightened level of vigilance is necessary for the prompt diagnosis of STSS in the emergency department. The diagnostic algorithm for STSS begins with the recognition of its signs and symptoms, followed by the localisation of the infection source and the acquisition of microbiological evidence of Streptococcus pyogenes infection. As bacteraemia is frequently present, obtaining blood cultures is considered the standard procedure. In the uncommon instances where STSS arises from tonsillitis, a swab from the tonsils is recommended [8]. The rapid test for the antigen of GAS may help us to find evidence of Streptococcus pyogenes infection faster than by using culture and may be useful in cases of STSS associated with tonsillitis. It has a relatively high sensitivity and acceptable specificity and is of high clinical value in the management of tonsillitis [14,15]. Sekizuka et al. described a case of STSS and pharyngitis in which a rapid test for the GAS antigen was also positive at the time of admission [2]. Therefore, these tests may help to diagnose STSS in cases with shock exanthema and sore throat, which may help to make the diagnosis quickly and administer appropriate treatment without delay. The main strength is that the results are available in a short period of time. The limitations are as follows: First, definitive diagnosis of STSS requires isolation of GAS from a sterile site, so the rapid antigen test cannot make a definitive diagnosis. Second, the rapid test does not provide information on the susceptibility of GAS to antimicrobial agents.
Treatment of STSS consists of supportive care for shock (fluid resuscitation, vasopressors, supplemental oxygen, renal replacement therapy if needed) and antimicrobial treatment, which should include high-dose beta-lactams and lincosamides. Penicillin remains the antimicrobial of choice for the treatment of GAS. Cephalosporins are also effective [16,17,18,19,20,21] and may be an alternative to penicillin in cases of penicillin allergy. This is particularly true of third-generation cephalosporins such as ceftriaxone and cefotaxime, which have a different R1 side chain to penicillin [22]. Lincosamides (clindamycin is the most commonly used), although bacteriostatic, are often used to treat severe streptococcal infections. They block the 50S subunit of the bacterial ribosome and inhibit the translation of streptococcal toxins. Therefore, the combination of lincosamides with penicillin is recommended [16,17].
There is evidence that adding clindamycin to beta-lactam therapy improves the prognosis of STSS. Notably, GAS resistance to clindamycin and macrolides is increasing [18,19,20]. This makes them unsuitable for monotherapy in STSS. Linezolid, which also inhibits photosynthesis, is very effective in treating severe GAS infections and could be used in the treatment of STSS [21]. Although penicillin alone will eventually stop toxin release, the combination of clindamycin or linezolid with penicillin results in a much faster decline in GAS toxin production than with penicillin alone [16]. The fact that clindamycin or linezolid should be added to treatment if STSS is suspected underlines the importance of early diagnosis of this disease. Therefore, point-of-care methods for GAS antigen assessment may improve the management of STSS by reducing the time delay between presentation and administration of appropriate antimicrobial treatment.
This case series has several limitations. First, one of the patients (case patient 1) cannot be definitively classified as a case of STSS due to the absence of GAS cultivation from a sterile site. Second, standardised diagnostic and treatment algorithms were not employed, resulting in variations in the diagnostic and therapeutic approaches used among the case patients. Third, we were unable to provide the images of the Streptococcus pyogenes cultures as the cultures were provided by a third-party laboratory.

4. Conclusions

In conclusion, STSS is a rare complication of GAS tonsillitis. It is a serious and potentially fatal condition with significant mortality, and prompt diagnosis, prompt antimicrobial therapy, and supportive therapy are essential for survival. A point-of-care antigen test for GAS antigen may be helpful in promptly diagnosing tonsillitis associated with STSS.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/clinpract15040070/s1, Reporting checklist for case report or case series.

Author Contributions

Conceptualization, P.M., P.S., S.K., K.L. and M.B.; methodology, P.M. and P.S.; writing—original draft preparation, P.M., S.K., K.L., M.B. and P.S.; writing—review and editing, P.M. and P.S.; supervision, P.S.; project administration, P.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this study due to our institutional policy which mentions that institutional ethics committee approval is not required in publishing case reports that do not describe any novel diagnostic and treatment management strategies, and do not involve any experimental data or sensitive personal data. Since the management of the case patients in our manuscript was in line with the current state of evidence-based medicine and respect current guidelines, and given that no new experimental data were collected and that all data were strictly anonymised, approval was not required. The CARE guidelines were followed to conduct and write the case series (Supplementary Materials).

Informed Consent Statement

Written informed consent has been obtained from the patients to publish this paper.

Data Availability Statement

The data can be made available on reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Schmitz, M.; Roux, X.; Huttner, B.; Pugin, J. Streptococcal toxic shock syndrome in the intensive care unit. Ann. Intensive Care 2018, 8, 88. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  2. Sekizuka, T.; Nai, E.; Yoshida, T.; Endo, S.; Hamajima, E.; Akiyama, S.; Ikuta, Y.; Obana, N.; Kawaguchi, T.; Hayashi, K.; et al. Streptococcal toxic shock syndrome caused by the dissemination of an invasive emm3/ST15 strain of Streptococcus pyogenes. BMC Infect. Dis. 2017, 17, 774. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  3. Al-ajmi, J.A.; Hill, P.; O’ Boyle, C.; Garcia, M.L.; Malkawi, M.; George, A.; Saleh, F.; Lukose, B.; Ali, B.A.; Elsheikh, M. Group A Streptococcus Toxic Shock Syndrome: An outbreak report and review of the literature. J. Infect. Public Health 2012, 5, 388–393. [Google Scholar] [CrossRef] [PubMed]
  4. Proft, T.; Fraser, J.D. Streptococcal superantigens: Biological properties and potential role in disease. In Streptococcus pyogenes: Basic Biology to Clinical Manifestations; Ferretti, J.J., Stevens, D.L., Fischetti, V.A., Eds.; The University Of Oklahoma Health Sciences Center: Oklahoma City, OK, USA, 2016. [Google Scholar]
  5. Commons, R.J.; Smeesters, P.R.; Proft, T.; Fraser, J.D.; Robins-Browne, R.; Curtis, N. Streptococcal superantigens: Categorization and clinical associations. Trends Mol. Med. 2014, 20, 48–62. [Google Scholar] [CrossRef] [PubMed]
  6. Proft, T.; Fraser, J.D. Streptococcal superantigens. Chem. Immunol. Allergy 2007, 93, 1–23. [Google Scholar] [CrossRef] [PubMed]
  7. Walker, M.J.; Barnett, T.C.; McArthur, J.D.; Cole, J.N.; Gillen, C.M.; Henningham, A.; Sriprakash, K.S.; Sanderson-Smith, M.L.; Nizet, V. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin. Microbiol. Rev. 2014, 27, 264–301. [Google Scholar] [CrossRef] [PubMed]
  8. Nelson, G.E.; Pondo, T.; Toews, K.A.; Farley, M.M.; Lindegren, M.L.; Lynfield, R.; Aragon, D.; Zansky, S.M.; Watt, J.P.; Cieslak, P.R.; et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Clin. Infect. Dis. 2016, 63, 478–486. [Google Scholar] [PubMed]
  9. Atchade, E.; De Tymowski, C.; Grall, N.; Tanaka, S.; Montravers, P. Toxic Shock Syndrome: A Literature Review. Antibiotics 2024, 13, 96. [Google Scholar] [CrossRef] [PubMed]
  10. Stevens, D.L. Streptococcal toxic shock syndrome. Clin. Microbiol. Infect. 2002, 8, 133–136. [Google Scholar] [CrossRef] [PubMed]
  11. Bryant, A.E.; Stevens, D.L. Streptococcus pyogenes. In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th ed.; Bennett, J., Dolin, R., Blaser, M., Eds.; Elsevier: Philadelphia, PA, USA, 2015; Volume 2, pp. 2285–2300. [Google Scholar]
  12. Lamagni, T.L.; Darenberg, J.; Luca-Harari, B.; Siljander, T.; Efstratiou, A.; Henriques-Normark, B.; Vuopio-Varkila, J.; Bouvet, A.; Creti, R.; Ekelund, K.; et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 2008, 46, 2359–2367. [Google Scholar] [PubMed]
  13. Vucicevic, Z.; Jajic-Bencic, I.; Kruslin, B.; Degoricija, V. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults. J. Microbiol. Immunol. Infect. 2009, 42, 276–279. [Google Scholar] [PubMed]
  14. Sølvik, U.Ø.; Boija, E.E.; Ekvall, S.; Jabbour, A.; Breivik, A.C.; Nordin, G.; Sandberg, S. Performance and user-friendliness of the rapid antigen detection tests QuickVue Dipstick Strep A test and DIAQUICK Strep A Blue Dipstick for pharyngotonsillitis caused by Streptococcus pyogenes in primary health care. Eur. J. Clin. Microbiol. Infect. Dis. 2021, 40, 549–558. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  15. Dodd, M.; Adolphe, A.; Parada, A.; Brett, M.; Culbreath, K.; Mercier, R.C. Clinical Impact of a Rapid Streptococcal Antigen Test on Antibiotic Use in Adult Patients. Diagn. Microbiol. Infect. Dis. 2018, 91, 339–344. [Google Scholar] [CrossRef] [PubMed]
  16. Coyle, E.A.; Cha, R.; Rybak, M.J. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob. Agents Chemother. 2003, 47, 1752–1755. [Google Scholar] [CrossRef]
  17. Linnér, A.; Darenberg, J.; Sjölin, J.; Henriques-Normark, B.; Norrby-Teglund, A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: A comparative observational study. Clin. Infect. Dis. 2014, 59, 851–857. [Google Scholar] [CrossRef]
  18. Liu, Z.; Jiang, X.; Li, J.; Ji, W.; Zhou, H.; Gong, X.; Miao, B.; Meng, S.; Duan, L.; Shi, Q.; et al. Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China. Front. Microbiol. 2023, 14, 1138039. [Google Scholar] [CrossRef]
  19. White, B.P.; Siegrist, E.A. Increasing clindamycin resistance in group A streptococcus. Lancet Infect. Dis. 2021, 21, 1208–1209. [Google Scholar] [CrossRef]
  20. Meletis, G.; Soulopoulos Ketikidis, A.L.; Floropoulou, N.; Tychala, A.; Kagkalou, G.; Vasilaki, O.; Mantzana, P.; Skoura, L.; Protonotariou, E. Antimicrobial resistance rates of Streptococcus pyogenes in a Greek tertiary care hospital: 6-year data and literature review. New Microbiol. 2023, 46, 37–42. [Google Scholar] [PubMed]
  21. Heil, E.L.; Kaur, H.; Atalla, A.; Basappa, S.; Mathew, M.; Seung, H.; Johnson, J.K.; Schrank, G.M. Comparison of Adjuvant Clindamycin vs. Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open Forum Infect. Dis. 2023, 10, ofad588. [Google Scholar] [CrossRef]
  22. Campagna, J.D.; Bond, M.C.; Schabelman, E.; Hayes, B.D. The use of cephalosporins in penicillin-allergic patients: A literature review. J. Emerg. Med. 2012, 42, 612–620. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Exanthema over the left arm in patient 1. On presentation, the exanthema presented as a maculopapular, partially confluent, salmon-pink rash with a sandpaper texture.
Figure 1. Exanthema over the left arm in patient 1. On presentation, the exanthema presented as a maculopapular, partially confluent, salmon-pink rash with a sandpaper texture.
Clinpract 15 00070 g001
Figure 2. Exanthema over the cubital area and left forearm in patient 1. On presentation, the exanthema presented as a maculopapular, partly confluent, salmon-pink rash with a sandpaper texture. In the cubital area, the exanthema was darker red.
Figure 2. Exanthema over the cubital area and left forearm in patient 1. On presentation, the exanthema presented as a maculopapular, partly confluent, salmon-pink rash with a sandpaper texture. In the cubital area, the exanthema was darker red.
Clinpract 15 00070 g002
Figure 3. Exanthema over the cubital area in patient 2. On presentation, the exanthema presented as a maculopapular salmon-pink rash with a sandpaper texture.
Figure 3. Exanthema over the cubital area in patient 2. On presentation, the exanthema presented as a maculopapular salmon-pink rash with a sandpaper texture.
Clinpract 15 00070 g003
Figure 4. Exanthema on the right forearm in patient 2. On presentation, the exanthema presented as a maculopapular salmon-pink rash with a sandpaper texture.
Figure 4. Exanthema on the right forearm in patient 2. On presentation, the exanthema presented as a maculopapular salmon-pink rash with a sandpaper texture.
Clinpract 15 00070 g004
Figure 5. Abdominal exanthema in patient 2. On presentation, the exanthema appeared as a maculopapular rash with a sandpaper-like texture. The exanthema was paler in the abdominal area than on the extremities.
Figure 5. Abdominal exanthema in patient 2. On presentation, the exanthema appeared as a maculopapular rash with a sandpaper-like texture. The exanthema was paler in the abdominal area than on the extremities.
Clinpract 15 00070 g005
Figure 6. The sign of strawberry tongue in the case of patient 2.
Figure 6. The sign of strawberry tongue in the case of patient 2.
Clinpract 15 00070 g006
Figure 7. A close-up of the exanthema (abdominal area) in patient 3. The papules have the typical “sandpaper” appearance.
Figure 7. A close-up of the exanthema (abdominal area) in patient 3. The papules have the typical “sandpaper” appearance.
Clinpract 15 00070 g007
Table 1. The vital signs, symptoms, signs, and results of the laboratory tests at the time of presentation.
Table 1. The vital signs, symptoms, signs, and results of the laboratory tests at the time of presentation.
Vital SignsPatient 1Patient 2Patient 3
Systolic blood pressure (mmHg)6088/5085
Diastolic blood pressure (mmHg)305052
Heart rate (beat/minute)160137110
Symptoms and signs
DyspnoeaPresentPresentPresent
FeverPresentPresentPresent
RashPresentPresentPresent
Strawberry tonguePresentPresentPresent
Laboratory results
C-reactive protein (mg/L)321268127
Procalcitonin (ng/mL)29.4182.73.3
Creatinine (umol/L)28082128
Interleukin-6 (pg/mL)996 1036438
Lactate (mmol/L)3.92.22.1
Neutrophil count (cells/mL)24,700950022,310
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mihalov, P.; Kovalíková, S.; Laktiš, K.; Bendžala, M.; Sabaka, P. Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series. Clin. Pract. 2025, 15, 70. https://doi.org/10.3390/clinpract15040070

AMA Style

Mihalov P, Kovalíková S, Laktiš K, Bendžala M, Sabaka P. Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series. Clinics and Practice. 2025; 15(4):70. https://doi.org/10.3390/clinpract15040070

Chicago/Turabian Style

Mihalov, Peter, Simona Kovalíková, Karol Laktiš, Matej Bendžala, and Peter Sabaka. 2025. "Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series" Clinics and Practice 15, no. 4: 70. https://doi.org/10.3390/clinpract15040070

APA Style

Mihalov, P., Kovalíková, S., Laktiš, K., Bendžala, M., & Sabaka, P. (2025). Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series. Clinics and Practice, 15(4), 70. https://doi.org/10.3390/clinpract15040070

Article Metrics

Back to TopTop